Targeted therapies for bone sarcomas

Tekijä Heymann, Dominique, Rédini, Françoise
Julkaistu 2013

Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma

Tekijä Redini, Françoise, Heymann, Dominique
Julkaisussa Front Oncol (2015)

Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment

Tekijä Verrecchia, Franck, Rédini, Françoise
Julkaisussa Front Oncol (2018)

RANKL/RANK/OPG: key therapeutic target in bone oncology

Tekijä Ando, Kosei, Mori, Kanji, Rédini, Françoise, Heymann, Dominique
Julkaistu 2008

TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment

Tekijä Picarda, Gaëlle, Trichet, Valérie, Téletchéa, Stéphane, Heymann, Dominique, Rédini, Françoise
Julkaistu 2011

Mifamurtide for the treatment of nonmetastatic osteosarcoma

Tekijä Ando, Kosei, Mori, Kanji, Corradini, Nadège, Redini, Françoise, Heymann, Dominique
Julkaistu 2011

SHH Signaling Pathway Drives Pediatric Bone Sarcoma Progression

Tekijä Lézot, Frédéric, Corre, Isabelle, Morice, Sarah, Rédini, Françoise, Verrecchia, Franck
Julkaisussa Cells (2020)

The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem

Tekijä Corre, Isabelle, Verrecchia, Franck, Crenn, Vincent, Redini, Francoise, Trichet, Valérie
Julkaisussa Cells (2020)

Antagonistic Functions of Connexin 43 during the Development of Primary or Secondary Bone Tumors

Tekijä Talbot, Julie, Dupuy, Maryne, Morice, Sarah, Rédini, Françoise, Verrecchia, Franck
Julkaisussa Biomolecules (2020)

New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?

Tekijä Danieau, Geoffroy, Morice, Sarah, Rédini, Françoise, Verrecchia, Franck, Brounais-Le Royer, Bénédicte
Julkaisussa Int J Mol Sci (2019)

Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers?

Tekijä Morice, Sarah, Danieau, Geoffroy, Rédini, Françoise, Brounais-Le-Royer, Bénédicte, Verrecchia, Franck
Julkaisussa Cancers (Basel) (2020)

Molecular Alterations Associated with Osteosarcoma Development

Tekijä Ando, Kosei, Mori, Kanji, Verrecchia, Franck, Marc, Baud'huin, Rédini, Françoise, Heymann, Dominique
Julkaistu 2012

Current Therapeutic Strategies and Novel Approaches in Osteosarcoma

Tekijä Ando, Kosei, Heymann, Marie-Françoise, Stresing, Verena, Mori, Kanji, Rédini, Françoise, Heymann, Dominique
Julkaistu 2013

Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases

Tekijä Lamora, Audrey, Mullard, Mathilde, Amiaud, Jérôme, Brion, Régis, Heymann, Dominique, Redini, Françoise, Verrecchia, Franck
Julkaisussa Oncotarget (2015)

TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression

Tekijä Lamora, Audrey, Talbot, Julie, Mullard, Mathilde, Brounais-Le Royer, Benedicte, Redini, Françoise, Verrecchia, Franck
Julkaisussa J Clin Med (2016)

A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis

Tekijä Le Goff, Benoit, Soltner, Elise, Charrier, Céline, Maugars, Yves, Rédini, Françoise, Heymann, Dominique, Berthelot, Jean-Marie
Julkaistu 2009

Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models

Tekijä Gobin, Bérengère, Moriceau, Gatien, Ory, Benjamin, Charrier, Céline, Brion, Régis, Blanchard, Frederic, Redini, Françoise, Heymann, Dominique
Julkaistu 2014

L-MTP-PE and zoledronic acid combination in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transfer

Tekijä Biteau, Kevin, Guiho, Romain, Chatelais, Mathias, Taurelle, Julien, Chesneau, Julie, Corradini, Nadège, Heymann, Dominique, Redini, Françoise
Julkaisussa Am J Cancer Res (2016)

Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma

Tekijä Lamoureux, Francois, Baud'huin, Marc, Ory, Benjamin, Guiho, Romain, Zoubeidi, Amina, Gleave, Martin, Heymann, Dominique, Rédini, Françoise
Julkaistu 2014

Receptor Activator of Nuclear Factor κB Ligand (RANKL)/Osteoprotegerin (OPG) Ratio Is Increased in Severe Osteolysis

Tekijä Grimaud, Eva, Soubigou, Luc, Couillaud, Séverine, Coipeau, Patrick, Moreau, Anne, Passuti, Norbert, Gouin, François, Redini, Françoise, Heymann, Dominique
Julkaistu 2003